This manuscript consists of a study of the results of 26 end stage renal failure (ESRF) patients, who commenced regular hemodialysis treatment (RHDT) from the age of 65 onwards (65-85) and who have been undergoing this treatment for periods ranging from 7 yr to 3 mo. These results are to be compared with those obtained from another group of 26 patients whose age ranged between 40 and 55 and who were treated with the same policy. The following parameters are compared: mortality, morbidity, life-style, cardiovascular situation, hypotension in hemodialysis, vascular access, anemia, osteoarticular and peripheral nervous disorders, hypertension. No significant differences between both groups, besides a higher morbidity for patients over 65, were found. The inclusion of the older patients into RHDT programs is therefore recommended.